Intravenous ferric derisomaltose in iron-deficient patients undergoing transcatheter aortic valve implantation due to severe aortic stenosis: study protocol of the randomised controlled IIISAS trial

INTRODUCTION: Iron deficiency is a prevalent comorbidity in patients with severe aortic stenosis and may be associated with procedural and clinical outcomes after transcatheter aortic valve implantation (TAVI). In the Intravenous Iron Supplement for Iron Deficiency in Patients with Severe Aortic Ste...

Descripción completa

Detalles Bibliográficos
Autores principales: Bardan, Sara, Kvaslerud, Anette Borger, Andresen, Kristoffer, Kløve, Sophie Foss, Edvardsen, Thor, Gullestad, Lars, Broch, Kaspar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442485/
https://www.ncbi.nlm.nih.gov/pubmed/36691165
http://dx.doi.org/10.1136/bmjopen-2021-059546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442485/
https://www.ncbi.nlm.nih.gov/pubmed/36691165
http://dx.doi.org/10.1136/bmjopen-2021-059546

Ejemplares similares